ganodermanontriol

CAS: 106518-63-2 C30 H48 O4 MW: 472.70936000

Identification

Nameganodermanontriol
CAS Number106518-63-2
FDA UNIISearch
Molecular FormulaC30 H48 O4
Molecular Weight472.70936000
MDL NumberMFCD07779162
Nikkaji NumberJ1.005.780I

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Soluble in water, 0.008667 mg/L @ 25 °C (est)

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorynatural substances and extractives
Recommendation for ganodermanontriol usage levels up tonot for fragrance use.
Recommendation for ganodermanontriol flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

ganoderma lucidum PMC

Synonyms

lanosta-7,9(11)-dien-3-one, 24,25,26-trihydroxy-, (24S,25R)- (5R,10S,13R,14R,17R)-4,4,10,13,14- pentamethyl-17-[(2R,5S)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one PubMed: Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens as telomerase inhibitors. PubMed: Tubulin polymerization-stimulating activity of Ganoderma triterpenoids. PubMed: Effects of Ganodermanondiol, a New Melanogenesis Inhibitor from the Medicinal Mushroom Ganoderma lucidum. PubMed: Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells. PubMed: In vitro and in vivo hepatoprotective effect of ganodermanontriol against t-BHP-induced oxidative stress. PubMed: Semisynthesis and biological evaluation of ganodermanontriol and its stereoisomeric triols. PubMed: Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. PubMed: Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. PubMed: Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling. PubMed: Triterpene-farnesyl hydroquinone conjugates from Ganoderma sinense. PubMed: New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. PubMed: Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. PubMed: Triterpene antioxidants from ganoderma lucidum. PubMed: Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. PubMed: Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.